glutathione level mda mb 468 Bar graphs representing the levels of GSH (reduced glutathione) and Frontiers | Compounds targeting ferroptosis
Frontiers Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential Mediator kinase inhibitors suppress triple negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitors PNAS Disclosing a metabolic signature of cisplatin resistance in MDA MB 231 triple negative breast cancer cells by NMR metabolomics Cancer Cell International Springer Nature Link F DDB derivative, a novel synthetic of bifendate, plus epirubicin improves antitumor efficacy against triple negative breast cancer without additional cardiotoxicity Discover Oncology Springer Nature Link
Pay in 4 interest-free payments of $5.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



